跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Symbiotics
首页
药物
Symbiotics
Symbiotics
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
METHODS FOR IMPROVING PLANT RESPONSE TO PESTS AND PATHOGENS
EP 4719062 A2
申请人: NEWLEAF SYMBIOTICS INC
优先权: 2023
EP
WO
2 件公开
Probiotic composition comprising at least two lactic acid bacterial strains which are able to clonise the gatrointestonal tracts in combination with having intestinal survival property, intestinal binding property, an infection protection property and fiber fermenting property
US 2007098705 A1
申请人: SYMBIOTICS AB
优先权: 2003
US
BACTERIA AND DERIVED PRODUCTS TO REINFORCE THE BODY DEFENCES AND TO REDUCE THE RISK OF DISEASE
US 2011177126 A1
申请人: CONSEJO SUPERIOR INVESTIGACION
优先权: 2008
US
COMPOSITION FOR IMPROVING INTESTINAL BARRIER FUNCTION
WO 2026121197 A1
申请人: MEIJI CO LTD
优先权: 2024
WO
药物
反馈